within Pharmacolibrary.Drugs.ATC.J;

model J01DB05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.95,
    Cl             = 2.08 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.018,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Cefadroxil is an orally administered first-generation cephalosporin antibiotic approved for the treatment of susceptible bacterial infections, including skin and soft tissue infections, urinary tract infections, and pharyngitis/tonsillitis. It is widely used and remains approved for clinical use in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters from healthy adult volunteers following single oral dose administration.</p><h4>References</h4><ol><li><p>Haynes, AS, et al., &amp; Fish, DN (2024). Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections. <i>Antimicrobial agents and chemotherapy</i> 68(5) e0018224–None. DOI:<a href=&quot;https://doi.org/10.1128/aac.00182-24&quot;>10.1128/aac.00182-24</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38597672/&quot;>https://pubmed.ncbi.nlm.nih.gov/38597672</a></p></li><li><p>Duffee, NE, et al., &amp; Schaeffer, DJ (1997). The pharmacokinetics of cefadroxil over a range of oral doses and animal ages in the foal. <i>Journal of veterinary pharmacology and therapeutics</i> 20(6) 427–433. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2885.1997.00085.x&quot;>10.1046/j.1365-2885.1997.00085.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9430765/&quot;>https://pubmed.ncbi.nlm.nih.gov/9430765</a></p></li><li><p>La Rosa, F, et al., &amp; Pfeffer, M (1982). Pharmacokinetics of cefadroxil after oral administration in humans. <i>Antimicrobial agents and chemotherapy</i> 21(2) 320–322. DOI:<a href=&quot;https://doi.org/10.1128/AAC.21.2.320&quot;>10.1128/AAC.21.2.320</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7073267/&quot;>https://pubmed.ncbi.nlm.nih.gov/7073267</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01DB05;
